Also keep in mind that CBIS products can and will be made available in other countries overseas. It is NOT just the US market we are talking about here. Other countries are light years ahead of the US when it comes to cannabis as a medicine, so I am sure that CBIS will be targeting those countries where the market is more receptive.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.